Shares of HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the sixteen brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $310.86.
Several equities research analysts recently weighed in on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $315.00 price objective on shares of HCA Healthcare in a research report on Thursday. Truist Financial increased their target price on shares of HCA Healthcare from $325.00 to $340.00 in a report on Tuesday, June 20th. Credit Suisse Group increased their target price on shares of HCA Healthcare from $311.00 to $316.00 and gave the stock an “outperform” rating in a report on Friday, July 28th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, September 12th. Finally, Mizuho upped their price objective on HCA Healthcare from $305.00 to $325.00 in a research note on Tuesday, July 11th.
Institutional Investors Weigh In On HCA Healthcare
Several hedge funds have recently made changes to their positions in HCA. Osaic Holdings Inc. raised its position in shares of HCA Healthcare by 5,225.7% in the 2nd quarter. Osaic Holdings Inc. now owns 2,351,561 shares of the company’s stock worth $16,178,000 after acquiring an additional 2,307,406 shares in the last quarter. Norges Bank bought a new position in shares of HCA Healthcare in the 4th quarter worth $547,104,000. Royal Bank of Canada increased its position in HCA Healthcare by 102.0% during the 2nd quarter. Royal Bank of Canada now owns 3,650,988 shares of the company’s stock valued at $1,108,001,000 after buying an additional 1,843,887 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in HCA Healthcare by 32.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,039,618 shares of the company’s stock valued at $1,689,226,000 after buying an additional 1,734,194 shares in the last quarter. Finally, Morgan Stanley increased its position in HCA Healthcare by 51.5% during the 4th quarter. Morgan Stanley now owns 2,229,190 shares of the company’s stock valued at $534,917,000 after buying an additional 758,127 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare Stock Down 2.8 %
HCA Healthcare stock opened at $256.28 on Monday. The company has a debt-to-equity ratio of 79.26, a current ratio of 1.20 and a quick ratio of 1.03. HCA Healthcare has a fifty-two week low of $178.32 and a fifty-two week high of $304.86. The company’s 50 day simple moving average is $276.42 and its 200 day simple moving average is $274.08. The firm has a market capitalization of $69.71 billion, a price-to-earnings ratio of 12.61, a PEG ratio of 1.35 and a beta of 1.60.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Thursday, July 27th. The company reported $4.29 EPS for the quarter, topping analysts’ consensus estimates of $4.28 by $0.01. The business had revenue of $15.86 billion for the quarter, compared to analyst estimates of $15.63 billion. HCA Healthcare had a net margin of 9.32% and a negative return on equity of 12,765.76%. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $4.21 earnings per share. As a group, sell-side analysts anticipate that HCA Healthcare will post 18.44 EPS for the current year.
HCA Healthcare Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 15th will be paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.94%. The ex-dividend date is Thursday, September 14th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.81%.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
- Five stocks we like better than HCA Healthcare
- What is the S&P/TSX Index?
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- MarketBeat Week in Review – 9/11 – 9/15
- Why Are Stock Sectors Important to Successful Investing?
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.